COVID-19 COVID-19

COVID-19

From Bench to Bedside

    • $114.99
    • $114.99

Publisher Description

The COVID-19 pandemic has affected the entire world in an unprecedented way, and this book provides an overview of the historical facts as well as ongoing approaches to tackle the COVID-19 pandemic. Experts of the respective domains provide details on anti-SARS-CoV-2 drug strategies, including repurposing drugs used for other indications and the development of novel drugs looking at different approaches to target virus entry and replication. COVID-19 vaccine development based on inactivated and attenuated live virus, protein subunit and peptide-based vaccines and utilization of vaccine candidates based on viral vectors, DNA and RNA are presented for both preclinical studies and clinical trials.

Key Features Explains the background of the COVID-19 pandemic, the current progress in the development of treatments and prevention of COVID-19 including future aspects of dealing with the pandemic Serves as a timely repository of knowledge on COVID-19 for researchers and medical professionals engaged in its management

GENRE
Professional & Technical
RELEASED
2022
March 3
LANGUAGE
EN
English
LENGTH
238
Pages
PUBLISHER
CRC Press
SELLER
Taylor & Francis Group
SIZE
42.3
MB
Viral, Parasitic, Bacterial, and Fungal Infections Viral, Parasitic, Bacterial, and Fungal Infections
2022
Dengue and Zika: Control and Antiviral Treatment Strategies Dengue and Zika: Control and Antiviral Treatment Strategies
2018
OMICS Applications in Crop Science OMICS Applications in Crop Science
2013
Deep Learning Applications in Translational Bioinformatics Deep Learning Applications in Translational Bioinformatics
2024
Omics Approaches and Technologies in COVID-19 Omics Approaches and Technologies in COVID-19
2022
Biotechnology in Healthcare, Volume 2 Biotechnology in Healthcare, Volume 2
2022
Biotechnology in Healthcare, Volume 1 Biotechnology in Healthcare, Volume 1
2022
Precision Medicine in Cancers and Non-Communicable Diseases Precision Medicine in Cancers and Non-Communicable Diseases
2018